CN1610542A - 用于治疗胃食管返流性疾病的新应用 - Google Patents
用于治疗胃食管返流性疾病的新应用 Download PDFInfo
- Publication number
- CN1610542A CN1610542A CNA028233514A CN02823351A CN1610542A CN 1610542 A CN1610542 A CN 1610542A CN A028233514 A CNA028233514 A CN A028233514A CN 02823351 A CN02823351 A CN 02823351A CN 1610542 A CN1610542 A CN 1610542A
- Authority
- CN
- China
- Prior art keywords
- receptor agonists
- cannabinoid receptor
- treatment
- application
- optical isomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Pyrane Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE01039361 | 2001-11-23 | ||
| SE0103936 | 2001-11-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1610542A true CN1610542A (zh) | 2005-04-27 |
Family
ID=20286096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA028233514A Pending CN1610542A (zh) | 2001-11-23 | 2002-11-20 | 用于治疗胃食管返流性疾病的新应用 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7358245B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1453497A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005511632A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20050044582A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1610542A (cg-RX-API-DMAC7.html) |
| AR (1) | AR037299A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2002353700A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0214319A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2466916A1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUP0402080A3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL161748A0 (cg-RX-API-DMAC7.html) |
| IS (1) | IS7272A (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04004774A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20042613L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ532844A (cg-RX-API-DMAC7.html) |
| PL (1) | PL369402A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2280443C2 (cg-RX-API-DMAC7.html) |
| TW (1) | TW200407110A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003043619A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200403785B (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103588672A (zh) * | 2013-10-28 | 2014-02-19 | 史克勇 | 一种治疗癌性疼痛的药物 |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0415851A (pt) * | 2003-10-24 | 2007-01-02 | Solvay Pharm Gmbh | utilizações médicas de compostos que apresentam atividade antagonìstica de cb1 e tratamento de combinação envolvendo os referidos compostos |
| WO2005060971A1 (en) * | 2003-12-18 | 2005-07-07 | Astrazeneca Ab | Treatment of reflux-related diseases |
| SE0303490D0 (sv) * | 2003-12-19 | 2003-12-19 | Astrazeneca Ab | New use V |
| RU2007119315A (ru) | 2004-10-25 | 2008-11-27 | Зольвай Фармасьютиклз Гмбх (De) | Фармацевтические композиции, содержащие антагонисты каннабиноидного рецептора св1 и открыватели калиевых каналов, предназначенные для лечения сахарного диабета типа i, ожирения и связанных с ними состояний |
| EP1827393A4 (en) * | 2004-12-09 | 2012-04-18 | Insys Therapeutics Inc | AT ROOM TEMPERATURE, STABLE DRONABINOL FORMULATIONS |
| US20080112895A1 (en) * | 2006-08-04 | 2008-05-15 | Insys Therapeutics Inc. | Aqueous dronabinol formulations |
| WO2009020666A1 (en) * | 2007-08-06 | 2009-02-12 | Insys Therapeutics Inc. | Oral cannabinoid liquid formulations and methods of treatment |
| US20110172305A1 (en) * | 2007-10-02 | 2011-07-14 | Ester Fride | Endocannabinoids for Enhancing Growth and Development in Infants |
| US20090208588A1 (en) * | 2008-02-19 | 2009-08-20 | Roger Wayne Brown | GERD carbohydrate compositions |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2735774B1 (fr) * | 1995-06-21 | 1997-09-12 | Sanofi Sa | Utilisation de composes agonistes du recepteur cb2 humain pour la preparation de medicaments immunomodulateurs, nouveaux composes agonistes du recepteur cb2 et les compositions pharmaceutiques les contenant |
| US6017919A (en) * | 1996-02-06 | 2000-01-25 | Japan Tobacco Inc. | Compounds and pharmaceutical use thereof |
| US5939429A (en) * | 1997-09-30 | 1999-08-17 | Virginia Commonwealth University | Cardiovascular uses of cannabinoid compounds |
| CA2340445A1 (en) * | 1998-05-04 | 1999-11-11 | The University Of Connecticut | Novel analgesic and immunomodulatory cannabinoids |
| CA2330681C (en) * | 1998-05-29 | 2008-08-26 | Andrea Giuffrida | Control of pain with endogenous cannabinoids |
| GB9923738D0 (en) | 1999-10-07 | 1999-12-08 | Nestle Sa | Nutritional composition |
| IL132661A (en) * | 1999-10-31 | 2008-11-26 | Raphael Mechoulam | Agonists specific for peripheral cannabinoid receptors |
| SE9904507D0 (sv) * | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
| KR100604742B1 (ko) * | 2000-06-15 | 2006-07-26 | 쉐링 코포레이션 | 트롬빈 수용체 길항제 |
| AUPR118000A0 (en) * | 2000-11-02 | 2000-11-23 | Amrad Operations Pty. Limited | Therapeutic molecules and methods |
| FR2816938B1 (fr) * | 2000-11-22 | 2003-01-03 | Sanofi Synthelabo | Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant |
| US20020077322A1 (en) * | 2000-12-15 | 2002-06-20 | Ayoub George S. | Protection of neurons against glutamate-induced damage in glaucoma and other conditions |
-
2002
- 2002-11-07 TW TW091132760A patent/TW200407110A/zh unknown
- 2002-11-11 AR ARP020104319A patent/AR037299A1/es not_active Application Discontinuation
- 2002-11-20 CN CNA028233514A patent/CN1610542A/zh active Pending
- 2002-11-20 US US10/496,431 patent/US7358245B2/en not_active Expired - Fee Related
- 2002-11-20 AU AU2002353700A patent/AU2002353700A1/en not_active Abandoned
- 2002-11-20 WO PCT/SE2002/002108 patent/WO2003043619A1/en not_active Ceased
- 2002-11-20 RU RU2004114843/15A patent/RU2280443C2/ru not_active IP Right Cessation
- 2002-11-20 CA CA002466916A patent/CA2466916A1/en not_active Abandoned
- 2002-11-20 BR BR0214319-4A patent/BR0214319A/pt not_active IP Right Cessation
- 2002-11-20 EP EP02789069A patent/EP1453497A1/en not_active Withdrawn
- 2002-11-20 KR KR1020047007819A patent/KR20050044582A/ko not_active Withdrawn
- 2002-11-20 MX MXPA04004774A patent/MXPA04004774A/es not_active Application Discontinuation
- 2002-11-20 HU HU0402080A patent/HUP0402080A3/hu unknown
- 2002-11-20 JP JP2003545300A patent/JP2005511632A/ja active Pending
- 2002-11-20 NZ NZ532844A patent/NZ532844A/en unknown
- 2002-11-20 IL IL16174802A patent/IL161748A0/xx unknown
- 2002-11-20 PL PL02369402A patent/PL369402A1/xx unknown
-
2004
- 2004-05-17 ZA ZA200403785A patent/ZA200403785B/en unknown
- 2004-05-19 IS IS7272A patent/IS7272A/is unknown
- 2004-06-22 NO NO20042613A patent/NO20042613L/no not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103588672A (zh) * | 2013-10-28 | 2014-02-19 | 史克勇 | 一种治疗癌性疼痛的药物 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1453497A1 (en) | 2004-09-08 |
| HUP0402080A2 (hu) | 2005-02-28 |
| TW200407110A (en) | 2004-05-16 |
| CA2466916A1 (en) | 2003-05-30 |
| AU2002353700A1 (en) | 2003-06-10 |
| ZA200403785B (en) | 2005-05-19 |
| NZ532844A (en) | 2005-12-23 |
| BR0214319A (pt) | 2004-11-03 |
| RU2004114843A (ru) | 2005-05-27 |
| JP2005511632A (ja) | 2005-04-28 |
| RU2280443C2 (ru) | 2006-07-27 |
| WO2003043619A1 (en) | 2003-05-30 |
| WO2003043619A8 (en) | 2005-03-17 |
| HUP0402080A3 (en) | 2008-03-28 |
| US20040266861A1 (en) | 2004-12-30 |
| NO20042613L (no) | 2004-08-13 |
| PL369402A1 (en) | 2005-04-18 |
| IS7272A (is) | 2004-05-19 |
| IL161748A0 (en) | 2005-11-20 |
| MXPA04004774A (es) | 2004-07-30 |
| KR20050044582A (ko) | 2005-05-12 |
| AR037299A1 (es) | 2004-11-03 |
| US7358245B2 (en) | 2008-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6824315B2 (ja) | 肥満の治療 | |
| TW202135796A (zh) | 口服大麻素調配物 | |
| CN1531420A (zh) | 用于有效施用阿扑吗啡、6аR-(-)-N-丙基-去甲阿扑吗啡和它们的衍生物及其前药的药物制剂 | |
| EP4358943A1 (en) | Naltrexone for boosting the therapeutic utility of 5-ht receptor agonists | |
| US7358245B2 (en) | Treatment of gastroesophageal reflux disease | |
| CN1649580A (zh) | 包含脂肪酶抑制剂和葡甘露聚糖的药物组合物 | |
| CN1968696A (zh) | 用于治疗和控制肺高血压的包含沙利度胺的组合物以及其使用方法 | |
| CN119095592A (zh) | 大麻素的不良心血管作用的治疗 | |
| WO2023100138A1 (en) | Oral cannabinoid compositions and methods for treating neurological diseases and disorders | |
| CN1491126A (zh) | 癌症治疗方法 | |
| CN1642576A (zh) | 吸收增强剂 | |
| CN1845737A (zh) | 富脂质斑的稳定化方法和破裂的预防方法 | |
| JP2005511632A5 (cg-RX-API-DMAC7.html) | ||
| JPWO2006003910A1 (ja) | メニエール病の予防および/または治療剤 | |
| CN1230178C (zh) | 伴有前列腺肥大症的膀胱刺激症状治疗药 | |
| WO2022020605A1 (en) | Treatment of metastasized estrogen receptor positive breast cancer | |
| JP4316793B2 (ja) | 過敏性腸症候群の治療剤 | |
| CN1660434A (zh) | 抗恶性肿瘤的药物组合物及其应用 | |
| WO2025207484A1 (en) | Use of aprepitant and cyclic dipeptide for weight control | |
| CA3235075A1 (en) | Methods of treating head and neck cancers with hemp extract | |
| WO2015001359A1 (en) | Drug combination and its use in therapy of obesity | |
| CN1915230A (zh) | 含有丹参酮iia磺酸钠的大容量注射液及其制备方法 | |
| HK1103657A (en) | Methods of using and compositions comprising thalidomide for the treatment and management of pulmonary hypertension | |
| CN101065124A (zh) | 用于防止前列腺增生向外科治疗转变的药物组合物 | |
| WO2015001358A1 (en) | Drug combination and its use in therapy of obesity and type ii diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |